Nevertheless, breast cancer with high immune activity not only enriched immune-related gene sets, but also enriched pro-cancer gene sets: KRAS signaling, PI3K/AKT/MTOR signaling, and apical surface gene sets. The gene discussed is KRAS; the disease is cancer.